UCB | Aspiring to be the patient-centric biopharma leader

- ucb.com

With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on severe diseases in two therapeutic areas – CNS and Immunology.

326,104 $ 15,660.00